May 15, 2009

TRANS GENIC INC.
   
Notice of Change of Directors
 

At its meeting held on May 15, 2009, the Board of Directors of TRANS GENIC INC. (headquartered in Kumamoto, Japan, CEO: Ken-ichi Yamamura) resolved that the following proposal for change of directors will be submitted to the 11th annual meeting of shareholders to be held on June 23, 2009.
 

1. Change of Directors
 
  (1) Candidates for new directors Kajitsudo Co., Ltd.
    Director Kenji FUKUNAGA
    Director Hiroshi NOSE
 
  (2) Intended retirement of directors
    Director

Masahiro KOREISHI
    Director

Jun TANAKA
 

2. Details of Candidates for New Directors
 

Name
(Date of Birth)
Career in Brief
Ratio to
the total number of shares issued (*)

Kenji FUKUNAGA
(August 13, 1969)

October, 1993

May, 2003
August, 2006

Joined Tohmatsu & Co. (Deloitte Touche Tohmatsu at present)
Director, Tohmatsu Venture Support Co., Ltd.
Established FUKUNAGA Accounting & Tax Service and became Representative (present)

Hiroshi NOSE
(August 28, 1964)

April, 1988

October, 2003
April, 2005


May, 2009

Joined Pharmaceutical Research Center, Meiji Seika Kaisha, Ltd.
Joined TRANS GENIC INC.
General Manager of Production Dept. (Research & development Dept. at present), Project Promotion Dept., TRANS GENIC INC. (present)
CEO, Primmune Inc. (present)

Tsuyoshi IDE
(March 6, 1961)

June, 1992

April, 1998
April, 2005

Joined Panapharm Laboratories Co., Ltd. (Mitsubishi Chemical Medience Corporation at present)
Established TRANS GENIC INC. and became CEO
Established Kajitsudo Co., Ltd. and became CEO (present)
 

Reference:
Members of the Board of Directors after the approval of the shareholders at the forthcoming annual general meeting (to be held on June 23, 2009)
 
    CEO Ken-ichi YAMAMURA
    Director Kenji FUKUNAGA
    Director Hiroshi NOSE
    Director Tsuyoshi IDE
 
PRINT
BACK